Three phase II cytokine working group trials of gp100 (210M) peptide plus high-dose interleukin-2 in patients with HLA-A2-positive advanced melanoma (Q37047969)

From Wikidata
Jump to navigation Jump to search
scientific article published on May 2008
edit
Language Label Description Also known as
English
Three phase II cytokine working group trials of gp100 (210M) peptide plus high-dose interleukin-2 in patients with HLA-A2-positive advanced melanoma
scientific article published on May 2008

    Statements

    Three phase II cytokine working group trials of gp100 (210M) peptide plus high-dose interleukin-2 in patients with HLA-A2-positive advanced melanoma (English)
    Jeffrey A Sosman
    Carole Carrillo
    Walter J Urba
    Lawrence Flaherty
    Michael B Atkins
    Joseph I Clark
    Janet Dutcher
    Kim A Margolin
    James Mier
    Jarod Gollob
    John M Kirkwood
    David J Panka
    Nancy A Crosby
    Kevin O'Boyle
    Bonnie LaFleur
    Marc S Ernstoff
    1 May 2008
    2292-2298

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit